Across TCGA pan-cancer cohorts, ACTG1P24 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated ACTG1P24 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ACTG1P24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ACTG1P24 expression acts as an unfavorable survival marker, although some lineages such as PAAD and UCS show a favorable association.

KIRC, PAAD, and STAD are the cancer types where ACTG1P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.568	0.721	.001	88	view →
PAAD	DFS	Median	All	0.544	0.224	<.001	66	view →
STAD	DFS	Tertile	IV	0.109	0.703	.006	35	view →
LGG	OS	Median	All	0.301	0.560	.001	35	view →
UCS	DFS	Quartile	II,III,IV	0.814	0.251	.002	32	view →
UVM	OS	Median	III,IV	0.214	0.768	.005	29	view →
BRCA	DFS	Quartile	III,IV	0.937	0.798	.003	23	view →
LIHC	OS	Quartile	III,IV	0.373	0.725	<.001	22	view →
LUSC	DFS	Quartile	III,IV	0.477	0.746	.005	21	view →
THYM	DFS	Tertile	II,III,IV	0.878	0.437	.003	20	view →
ACC	DFS	Median	All	0.154	0.588	.006	20	view →
COAD	DFS	Median	IV	0.342	0.621	.005	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration

Same gene, other analysis: ACTG1P24 tumor-vs-normal RNA expression · all ACTG1P24 data types